EUVIMEDEUVIMED entdecken
EUVIMED · CrossrefZeitschrift

Radiotherapy and Oncology

ISSN 0167-8140 · Elsevier BV

Neueste Artikel

  1. Sleep-related symptoms are associated with survival in oropharyngeal cancer radiotherapy survivors: Temporal characterization of patient-reported outcomes in a large-scale prospective longitudinal cohort

    Glennon Carevic, Warren Floyd, Rishabh Gaur, Cem Dede, Lucas McCullum, Sarah Mirbahaeddin, Cesar Marquez, Saadia A. Faiz, Mai Mandor Badawy, Amit Jethanandani, G.Elisabeta Marai, Abdallah Sherif Radwan Mohamed, Jacob Mathew, Guadalupe Canahuate, Naser Mohamed, Jack Phan, Sigmund Haidacher, Michael Spiotto, Anna Lee, Katherine A. Hutcheson, Amy C. Moreno, Clifton D. Fuller

    Erschienen: 2027-01DOI: 10.1016/j.radonc.2026.111778

  2. Repeated metastasis-directed radiotherapy in patients with oligorecurrent prostate cancer: outcomes and risk stratification from a large multinational PSMA PET-guided cohort

    Ruth van der Walle, Tessa D. van Bergen, Marcin Miszczyk, Max Peters, Mateusz Bilski, Giulio Francolini, Pietro Garlatti, Maris Mezeckis, Justyna Kociolek, Frederik R. Teunissen, Paulien G. Westhoff, Arthur J.A.T. Braat, Cornelis A.T. van den Berg, Shahrokh F. Shariat, Wietse S.C. Eppinga, Shafak Aluwini, Timo F.W. Soeterik

    Erschienen: 2027-01DOI: 10.1016/j.radonc.2026.111821

  3. IAP inhibition enhances response to radiotherapy and chemotherapy in preclinical models of rectal cancer

    Timothy O’Brien, Thomas Wright, Matilda Downs, Shaun Sharkey, Catherine Higgins, Jaine Blayney, Fiza M.F. Ishaqwala, Liang Tang, Ashley K. McCulloch, Chia Y. Kong, Lily V.S. Hillson, Ross K. McMahon, Sean M. O’Cathail, Kathryn Pennel, Joanne Edwards, Karl Butterworth, Tomoko Smyth, George Ward, Melissa LaBonte-Wilson, Simon McDade, Catherine Hanna, Campbell Roxburgh, Victoria M. Coyle, Daniel B Longley

    Erschienen: 2027-01DOI: 10.1016/j.radonc.2026.111832

  4. Carbon ion radiotherapy for non-metastatic pancreatic cancer: final results of the prospective phase 2 PACK-study (NCT04194268)

    Jakob Liermann, Patrick Naumann, Cornelia Jäkel, Lukas Baumann, Beata Koczur, Manuel Röhrich, Felix H. Englert, Inga Jessen, Bouchra Tawk, Maximilian Knoll, Filipa Baltazar, Semi Harrabi, Christoph Springfeld, Christoph Michalski, Uwe Haberkorn, Andrea Mairani, Amir Abdollahi, Meinhard Kieser, Jürgen Debus, Klaus Herfarth

    Erschienen: 2027-01DOI: 10.1016/j.radonc.2026.111836

  5. MRI-guided HDR brachytherapy or integrated VMAT boost for tumour-targeted dose escalation in localised prostate cancer: long-term results of the TARGET study

    Jerusha Padayachee, Noelia Sanmamed, Xiang Y. Ye, Zhihui Amy Liu, Jenny Lee, Alejandro Berlin, Tim Craig, Bernadeth Lao, Alexandra Rink, Andrew Bayley, Charles Catton, Warren Foltz, Andrew McPartlin, Sangeet Ghai, Rachel M. Glicksman, Mary Gospodarowicz, Padraig Warde, Cynthia Ménard, Peter Chung

    Erschienen: 2027-01DOI: 10.1016/j.radonc.2026.111853

  6. Quality of life and pain-response after stereotactic ablative radiotherapy of oligometastatic bone metastases in the phase 2 BONY-M trial

    Nicklas Juel Spindler, Sebastian Moretto Krog, Mette van Overeem Felter, Olfred Hansen, Tine Bjørn Nielsen, Morten Hiul Suppli, Mirjana Josipovic, Laurids Østergaard Poulsen, Fatma Rahma-Petersen, Hella Maria Brøgger Sand, Tatiana Mikhailovna Abramova, Marie Johansen, Josefine Stahl Kornerup, Mirjam Delange Alsaker, Rikke Løvendahl Eefsen, Kasper Madsen, Eva Serup-Hansen, Henriette Lindberg, Ivan Richter Vogelius, Claus Preibisch Behrens, Gitte Fredberg Persson

    Erschienen: 2026-12DOI: 10.1016/j.radonc.2026.111774

  7. Lessons learned from the multicentre QA program in SBRT for perihilar cholangiocarcinoma: benchmark-case results from the STRONG II trial

    Suus Y. van Loosbroek, Maaike T.W. Milder, François Willemssen, Wilhelm den Toom, Martijn Intven, Gert J. Meijer, Christelle Bouchart, Akos Gulyban, Eva Versteijne, Anna M. Bruynzeel, Miguel A. Palacios, Ines Joye, Matthias Hermans, Jeroen Buijsen, Richard Canters, Pètra M. Braam, Ruud G.H. van Leeuwen, Margriet Dieters, Fred J.F. Ubbels, Vincent C. Hamming, Ben Heijmen, Alejandra Méndez Romero

    Erschienen: 2026-12DOI: 10.1016/j.radonc.2026.111781

  8. Enabling gantry-less radiotherapy through upright patient positioning: Current consensus and future direction

    Petra Trnkova, Tracy Underwood, Rasmus Bokrantz, Erik Engwall, Carri Glide-Hurst, Cristina Garibaldi, Lars Glimelius, Taku Inaniva, Oliver Jäkel, Simon Jolly, Tony Lomax, Maria Chiara Martire, Vincenzo Patera, Lorenzo Placidi, Alexander Pryanichnikov, Ilaria Rinaldi, Gordon Sands, Esther G.C. Troost, Alessandro Vai, Ye Zhang, Lennart Volz

    Erschienen: 2026-12DOI: 10.1016/j.radonc.2026.111785

  9. Multi-center comparison of relative stopping power estimation of an ex vivo phantom using clinical X-ray CT scanners and a proton CT prototype

    Elena Fogazzi, Esther Bär, Mara Bruzzi, Mario Ciocca, Carlo Civinini, Paolo Farace, Francesco Fracchiolla, Callum Gillies, Guyue Hu, Guillaume Landry, Stefano Lorentini, Katia Parodi, Christian Richter, Roberto Righetto, Ilaria Rinaldi, Monica Scaringella, Julian Schwengfelder, Alessandro Vai, Enrico Verroi, Francesco Tommasino

    Erschienen: 2026-12DOI: 10.1016/j.radonc.2026.111787

Jahrgänge

2027 · 212026 · 4.1142025 · 3.4562024 · 3.7712023 · 3.0072022 · 2.4692021 · 2.9182020 · 2.6792019 · 3.2442018 · 2.7712017 · 2.3692016 · 3.0142015 · 2.2372014 · 2.5302013 · 1.8482012 · 2.7672011 · 2.1752010 · 5432009 · 1.4192008 · 3722007 · 5782006 · 8082005 · 1.2302004 · 2.1302003 · 9742002 · 1.5532001 · 1.3372000 · 4191999 · 1721998 · 3221997 · 2171996 · 1.2541995 · 4601994 · 3341993 · 2261992 · 1821991 · 2121990 · 1851989 · 1531988 · 158

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.